| Financial Year |
March 31 2023 |
| Monetary Funds |
4,242,106,930.26 |
| Held-for-trading Financial Assets |
21,013,074,245.30 |
| Notes Receivable |
-- |
| Accounts Receivable |
616,131,837.97 |
| Advances to Suppliers |
104,502,642.72 |
| Other Receivables |
1,706,955,611.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
55,369,649.12 |
| Dividend Receivable |
80,422,000.00 |
| Inventories |
37,325,070,422.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,886,065,148.47 |
| Other Current Assets |
1,445,636,429.67 |
| Total Current Assets |
73,395,652,471.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,528,515.65 |
| Long-term Equity Investment |
9,935,745,361.52 |
| Investment Properties |
3,192,965,737.78 |
| Fixed Assetes |
3,106,085,592.48 |
| Under-construction Projects |
30,660,262.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
526,003.82 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
375,661,964.27 |
| R&D expenses |
6,319,335.36 |
| Goodwill |
2,518,407,400.45 |
| Long-Term Deferred and Prepaid Expenses |
81,971,843.98 |
| Deferred Income Tax Assets |
3,678,766,400.30 |
| Other Non-Current Assets |
8,969,102,949.04 |
| Sub-Total of Non-Current Assets |
76,245,954,268.25 |
| Total Assets |
149,641,606,739.35 |
| Short-Term Loans |
1,379,106,205.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,483,040,484.13 |
| Accounts Received In Advance |
20,262,700.27 |
| Employee Compensation Payable |
298,937,112.22 |
| Taxes Payable |
3,476,108,683.56 |
| Interest Payable |
1,772,698,779.74 |
| Dividend Payable |
7,579,030.47 |
| Other payables |
14,970,609,891.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,746,201,809.63 |
| Other Current Liabilities |
3,338,484,455.60 |
| Sub-Total of Current Liabilities |
68,777,511,484.06 |
| Long-term Loans |
2,759,903,254.66 |
| Bonds Payable |
5,750,020,634.99 |
| Long-Term Accounts Payable |
2,934,144,475.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
231,640,938.05 |
| Other Non-Current Liabilities |
28,673,807,421.01 |
| Sub-Total of Non-Current Liabilities |
92,431,217,710.07 |
| Total Liabilities |
161,208,729,194.13 |
| Paid-In Capital(Or Share Stock) |
7,005,254,679.00 |
| Capital Surplus |
1,075,833,756.93 |
| Surplus Reserve |
1,196,414,917.26 |
| LESS:Treasury Stock |
83,565,705.68 |
| Undistributed Profits |
-14,944,461,763.21 |
| Minority Stockholder's Interest |
-5,558,589,481.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-6,008,532,973.41 |
| Owner's Equity（Stockholder's Equity） |
-11,567,122,454.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
149,641,606,739.35 |
